Trials / Unknown
UnknownNCT05580107
MDPK67b in Patients With Prostate Cancer
Open-label Phase Ib Study of Preoperative Treatment With the KLK Inhibitor MDPK67b in Patients With Untreated Prostate Cancer
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Med Discovery SA · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Administration of MDPK67b to assess its Tolerability and Safety profile in prostate cancer patients, and to assess histo-pathological and molecular changes in prostate tumor tissue samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MDPK67b | 24 mg or 48 mg |
Timeline
- Start date
- 2021-08-09
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
- First posted
- 2022-10-14
- Last updated
- 2023-11-07
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05580107. Inclusion in this directory is not an endorsement.